Home
Oncology
Oncology Pipeline
LipoADC™ Platform – K1
TRAFsome™ T cell Engager – HF50
Immune Modulator – K16
Gene Therapy
Gene Therapy Pipeline
HFG1
Facilities
About
News & Publications
Contact
简体中文
Home
Oncology
Oncology Pipeline
LipoADC™ Platform – K1
TRAFsome™ T cell Engager – HF50
Immune Modulator – K16
Gene Therapy
Gene Therapy Pipeline
HFG1
Facilities
About
News & Publications
Contact
简体中文
January 13, 2025
Studies by HighField Biopharmaceuticals Show Advantages of Lipid Structure Design for Applying LNP Non-Viral Gene Therapies to Complex Diseases
by
PJWCreative
English
English
简体中文
English
English
简体中文